Social Cognitive Training for Psychosis: Treatment Development
This study is not yet open for participant recruitment.
Verified April 2012 by Yale University
Sponsor:
Yale University
Collaborator:
Information provided by (Responsible Party):
Joanna Fiszdon, Yale University
ClinicalTrials.gov Identifier:
NCT01579422
First received: April 10, 2012
Last updated: April 16, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The primary aim of this proposal is to develop, refine, manualize and assess the feasibility and preliminary efficacy of a brief, narrowly-focused social cognitive intervention for individuals with psychosis. The intervention will focus on helping individuals interpret social situations, specifically the intentions and feelings of others.
Study methods include preliminary treatment and manual development based on series of uncontrolled cases, manual refinement, and a small feasibility/efficacy trial of the newly developed intervention.
| Condition | Intervention | Phase |
|---|---|---|
|
Schizophrenia Psychosis |
Behavioral: social cognitive training |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Social Cognitive Training for Psychosis: Phase I Treatment Development |
Resource links provided by NLM:
Further study details as provided by Yale University:
Primary Outcome Measures:
- social cognition [ Time Frame: change from baseline to approximately 6 weeks ] [ Designated as safety issue: No ]AIHQ Eyes Task Hinting Task IPSAQ
| Estimated Enrollment: | 40 |
| Study Start Date: | May 2012 |
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: social cognitive training |
Behavioral: social cognitive training
social cognitive training, 8-10 sessions
|
Eligibility| Ages Eligible for Study: | 18 Years to 55 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Diagnosis of schizophrenia or other psychotic disorder
- Age between 18 and 55
- Psychiatrically stable
- Clinician agrees to individual's participation in study
- English as primary language
Exclusion Criteria:
- current (past 30 days) symptoms of alcohol abuse/dependence
- developmental disability
- severe auditory/visual impairment or known neurological disorder
- participant has a legal conservator
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01579422
Contacts
| Contact: Joanna Fiszdon, Ph.D. | 203-932-5711 ext 2231 | joanna.fiszdon@yale.edu |
Locations
| United States, Connecticut | |
| VA Connecticut Healthcare System | |
| West Haven, Connecticut, United States, 06516 | |
Sponsors and Collaborators
Yale University
More Information
No publications provided
| Responsible Party: | Joanna Fiszdon, Associate Professor, Yale University |
| ClinicalTrials.gov Identifier: | NCT01579422 History of Changes |
| Other Study ID Numbers: | A08405, 1R34MH090109 |
| Study First Received: | April 10, 2012 |
| Last Updated: | April 16, 2012 |
| Health Authority: | United States: Institutional Review Board United States: Federal Government |
Keywords provided by Yale University:
|
schizophrenia treatment social cognition |
Additional relevant MeSH terms:
|
Mental Disorders Psychotic Disorders Schizophrenia Schizophrenia and Disorders with Psychotic Features |
ClinicalTrials.gov processed this record on June 18, 2013